Nocturnal blood pressure (BP) and blunted nocturnal BP dipping (nondipping) are associated with increased cardiovascular mortality and morbidity, independent of office BP and cardiovascular risk factors. 1,2 Moreover, in a longitudinal study (~9 years follow-up), nocturnal BP and nondipping conveyed risk for the development of congestive heart failure (HF), excluding myocardial infarction, beyond office BP, and cardiovascular risk factors. 3 In addition, in patients with HF, nondipping has been independently associated with both HF with reduced ejection fraction (EF) as well as HF with preserved EF. 4 However, patients in HF have increased activation of the sympathetic nervous system as well as the renin-angiotensin-aldosterone system, 5 both of which have been implicated in the blunting of nocturnal BP dipping. 6, 7 Hence, whether nondipping is causally related to reductions in cardiac systolic function prior to the development of HF is unclear.
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Nocturnal blood pressure (BP) and blunted nocturnal BP dipping (nondipping) are associated with increased cardiovascular mortality and morbidity, independent of office BP and cardiovascular risk factors. 1, 2 Moreover, in a longitudinal study (~9 years follow-up), nocturnal BP and nondipping conveyed risk for the development of congestive heart failure (HF), excluding myocardial infarction, beyond office BP, and cardiovascular risk factors. 3 In addition, in patients with HF, nondipping has been independently associated with both HF with reduced ejection fraction (EF) as well as HF with preserved EF. 4 However, patients in HF have increased activation of the sympathetic nervous system as well as the renin-angiotensin-aldosterone system, 5 both of which have been implicated in the blunting of nocturnal BP dipping. 6, 7 Hence, whether nondipping is causally related to reductions in cardiac systolic function prior to the development of HF is unclear.
Although a number of previous studies have explored the relationship between BP dipping and cardiac diastolic function, there is limited data on cardiac systolic function. Indeed, a recent systematic review and meta-analysis in untreated hypertensives reported increases in left ventricular mass index (LVMI), relative wall thickness (RWT), and left atrial diameter and reductions in the ratio of early (E) to late (A) mitral inflow velocity (E/A ratio) (not significant after correction for publication bias) in nondippers compared to dippers. 8 However, no studies assessing cardiac systolic function were included in this systematic review and meta-analysis.
To our knowledge, only 2 previous small (n = 56-133) studies 9, 10 and 1 large study (n = 1,702) 11 have assessed the impact of BP dipping on cardiac systolic function in participants not receiving antihypertensive therapy. As antihypertensive therapy has an impact on both BP dipping [12] [13] [14] and cardiac function, it is important that only untreated participants are assessed in order to avoid the potential confounding effects of treatment. Although in both of the previous small studies, 9, 10 EF was decreased in nondippers compared to dippers, in comparing these 2 groups of participants no adjustments were made for potential confounding variables. In this regard, several factors are associated with blunted nocturnal BP dipping include age, 15, 16 sex, 15, 16 obesity, 15 ,16 insulin resistance, 17 BP level, 16 pulse wave velocity (PWV), 18, 19 total peripheral resistance (TPR), 20 LVMI, 21 and RWT. 21 Moreover, although relations between cardiac systolic function and day-night BP changes were noted in the large study, 11 patients with a depressed systolic function also had a higher LVMI and a more concentric geometry. In addition, in this large study, adjustments were made for only age and sex. 11 Hence, in the present study, we assessed whether the nocturnal BP dipping pattern and nocturnal BP were associated with indexes of cardiac systolic function [endocardial fractional shortening (endFS), midwall FS (mFS), EF] independent of LVMI and RWT in randomly selected participants not receiving antihypertensive therapy from an urban, developing community. In addition, we assessed whether relationships between nocturnal BP dipping and indexes of cardiac systolic function were explained by variations in PWV, TPR, or insulin resistance.
METHODS

Study group
The present study was approved by the Committee for Research on Human Subjects of the University of the Witwatersrand (approval number: M02-04-72, renewed as M07-04-69, M12-04-108, and M17-04-01). Participants gave informed written consent. The study design and the population sampled has previously been described. [22] [23] [24] [25] Briefly, 1,445 participants older than 16 years of age from nuclear families of Black African ancestry (Nguni and Sotho chiefdoms) were randomly recruited from the South West Township (SOWETO) of Johannesburg, South Africa from 2002 to 2017 using the population census figures of 2001. Of these participants, 1,082 were not receiving antihypertensive therapy, and in a substudy, 491 had both 24-hour ambulatory BP monitoring that met with the European Society of Hypertension (ESH) guidelines (longer than 14 and 7 readings for the computation of day and night means, respectively), 26 and echocardiographic assessments.
Clinical, demographic, and anthropometric measurements
A standardized questionnaire was administered to obtain demographic and clinical data as previously described. [22] [23] [24] [25] As this was a community-based study, nontreatment of hypertension was by self-report on the questionnaire. In addition, however, the participants brought all prescribed medications with them so that the medications could be confirmed as antihypertensive agents or not. Conventional BP was determined from the mean of 5 nurse-derived BP measurements obtained with a mercury sphygmomanometer as previously described. 24 From height and weight measurements, body mass index (BMI) was calculated and participants were identified as being overweight if their BMI was ≥25 kg/m 2 and obese if their BMI was ≥30 kg/m 2 . Waist circumference was assessed using a standard approach. Blood lipid profiles and percentage glycated hemoglobin (HbA 1c ) were determined. Diabetes mellitus or abnormal blood glucose control was defined as the use of insulin or oral hypoglycemic agents or an HbA 1c value greater than 6.1%. 27 Participants were classified as hypertensive if conventional BP values were ≥140/90 mm Hg. Fasting plasma insulin concentrations were determined from an insulin Immulite, solid phase, 2-site chemiluminescent immunometric assay (Diagnostic Products Corporation, Los Angeles, CA). Insulin resistance was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR) using the formula (insulin [μU/ ml] × glucose [mmol/l])/22.5.
Ambulatory BP
Twenty four-hour ambulatory BP monitoring was performed using oscillometric monitors (SpaceLabs, model 90207) as previously described (see online Supplemental Methods). 24, 25 The average (±SD) number of BP readings obtained was 59.8 ± 12.2 (range = 24-81) for the 24-hour period, 29.5 ± 6.6 (range = 14-41) for the day and 9.6 ± 0.8 (range = 7-11) for the night periods. Systolic and diastolic BP dipping were calculated for each participant as nightto-day BP ratio expressed as a percentage. Four BP dipping patterns (extreme dipper, dipper, nondipper, reverse dipper) were defined as extreme dipper if night-to-day BP ratio was ≤0.8; dipper if night-to-day BP ratio >0.8 and ≤0.9; nondipper if night-to-day BP ratio >0.9 and ≤1.0; and reverse dipper if night-to-day BP ratio >1.0. 2, 28 Pulse wave analysis On the same day as ambulatory BP monitoring was performed, aortic (carotid-femoral) PWV was estimated using carotid and femoral applanation tonomtery (highfidelity SPC-301 micromanometer, Millar Instrument, Inc., Houston, TX) interfaced with a computer employing SphygmoCor, version 9.0 software (AtCor Medical Pty. Ltd., West Ryde, New South Wales, Australia) as described previously (see online Supplementary Data). 22, 24 
Echocardiography
Echocardiographic measurements were recorded and analyzed offline by experienced investigators who were unaware of the clinical data of the participants and whom had a low degree of interobserver and intraobserver variability. 29 The LV dimensions were measured only when appropriate visualization of both the right and the left septal surfaces occurred and where the endocardial surfaces of both the septal and posterior wall were clearly visible. Left ventricular EF was calculated using the biplane Simpson method. In addition, left ventricular function was assessed at both the chamber (endFS) and the mFS level. Midwall FS was calculated using a modified ellipsoidal model as previously described 30 which accounts for epicardial migration of the midwall during systole. Total peripheral resistance was calculated as mean arterial pressure/cardiac output. Left ventricular mass index was determined from transthoracic 2-dimensional targeted M-mode echocardiography with the participants in the partial left decubitus position, as previously described. 24, 29 Echocardiography recordings were analyzed according to the American Society of Echocardiography convention. 30 Left ventricular mass was determined using a standard formula 31 and indexed (LVMI) to height 1.7 . Left ventricular hypertrophy was identified as LVMI >80 g/m 1.7 for men and >60 g/m 1.7 for women. 32 Left ventricular diastolic function was assessed from a pulsed wave Doppler examination of the mitral inflow at rest and using TDI (see online Supplementary Data). 33 
Data analysis
For database management and statistical analysis, SAS software, version 9.4 (SAS Institute Inc., Cary, NC) was employed. Data are shown as mean ± SD. Multivariateadjusted linear (continuous data) or logistic (discrete data) regression analysis was performed to determine independent relations. Potential confounders were identified on bivariate relationships with indexes of cardiac function or BP dipping. In multivariate analyses adjustments were made for age, sex, BMI, regular smoking, regular alcohol consumption, diabetes mellitus, and/or HbA 1c >6.1%, 24 hour (or day) heart rate, and 24 hour (or day) BP. To determine whether BP dipping vs. cardiac function relations were independent of LVMI or RWT, further adjustments were made for LVMI and RWT, respectively. Similarly, to determine whether relationships between nocturnal BP dipping and indexes of cardiac systolic function were explained by variations in PWV, TPR, or insulin resistance, in separate models further adjustments were made for PWV, TPR, or log HOMA-IR (transformed to improve distribution).
RESULTS
Characteristics of the participants
Comparisons between the characteristics of those included and those not included in the study are shown in the online supplement (Supplementary Table S1 ). Participants with 24-hour ambulatory BP monitoring and high-quality echocardiographic data had similar characteristics to participants without either high-quality 24-hour ambulatory BP monitoring or echocardiographic data. Table 1 compares the characteristics of the participants in the 4 SBP dipping patterns. The reverse dippers were older and had a higher BMI than the dippers. Moreover, the reverse dippers had higher 24-hour BP, night BP, and TPR but not day BP and day HR than the other 3 groups. The nondippers also had a higher night BP than the dippers and extreme dippers; but day BP was lower than the extreme dippers. The reverse dippers had an increased night HR than the dippers, but neither 24 hour nor day HR differed from that of the other 3 groups. Neither LVMI, nor the proportion of participants with LV hypertrophy differed across the 4 groups (extreme dippers = 39.5%, dippers = 35.7%, nondippers = 40.6%; reverse dippers = 48.0%). Supplementary Table S2 compares the characteristics of the participants who were dippers compared to those who were nondippers according to SBP. The nondippers were older and had a higher BMI, PWV, 24 hour BP, night BP, and night HR; but not day BP.
Factors associated with BP dipping
The factors associated with indexes of BP dipping on bivariate analyses are shown in Supplementary Table S3 . Night-to-day BP ratios were associated with night but not day BP. Night-to-day BP ratios were also associated with age, BMI, and hypertension. Although sex, diabetes mellitus, or an HbA 1c >6.1%, regular smoking and drinking were associated with night and/or day BP values, these factors were not associated with night-to-day BP ratios.
Relationships between BP dipping, day and night BP and indexes of cardiac systolic and diastolic function
On bivariate analysis, EF, endFS, and mFS were correlated with BP dipping (night-to-day BP ratios) and night BP; but not day BP (Table 2 ). In comparison, E/A and E/e' were associated with BP dipping and both night and day BP ( Table 2) . After adjusting for confounding variables in multivariate analyses including 24-hour BP (Table 3) or day BP  (Supplementary Table S4 ), the associations of EF, endFS, and mFS with BP dipping and night BP remained (Table 3 and  Supplementary Table S4 ). With regards to indexes of cardiac diastolic function, on multivariate analyses no relationships with indexes of BP dipping were noted (Table 3 and  Supplementary Table S4 ). The multivariate-adjusted relationships between BP dipping or night BP and EF, endFS, and mFS survived further adjustments for either LVMI or RWT (Table 4 and Supplementary Table S5 ) and were not explained by variations in PWV or log HOMA-IR (Table 4  and Supplementary Table S5 ). Further adjustments for TPR had no impact on the relationships between EF or endFS and BP dipping. However, the multivariate relationships between SBP dipping or night SBP (but not DBP) and mFS were abolished by further adjustments for TPR (Table 4 and  Supplementary Table S5) .
Relationships between BP dipping pattern and indexes of cardiac systolic function Figure 1 shows the multivariate-adjusted mean values of indexes of cardiac systolic function in the 4 BP dipping patterns. When dipping pattern was defined according to systolic BP, extreme dippers had significantly increased EF, endFS, and mFS compared to the other 3 groups (Figure 1 , upper panels). However, when dipping pattern was defined according to diastolic BP, reverse dippers had significantly decreased EF, endFS, and mFS compared to the other 3 groups (Figure 1 , lower panels). When nondippers were compared to dippers defined according to systolic BP, r, correlation coefficient; SBPn/SBPd ratio, ratio of night SBP to day SBP; DBPn/DBPd ratio, ratio of night DBP to day DBP; SBPn, night SBP; DBPn, night DBP; SBPd, day SBP; DBPd, day DBP; EF, ejection fraction; endFS, endocardial fractional shortening; mFS, midwall fractional shortening; E/A, left ventricular early-to-late transmitral flow velocity; E/e', early transmitral blood flow velocity/mean of lateral and septal wall myocardial tissue lengthening at the mitral annulus; LVMI, left ventricular mass indexed to height 1.7 ; RWT, relative wall thickness. Values are mean ± SD or proportions. SBP dipping patterns: extreme dipper = SBPn/SBPd ≤0.8; dipper = SBPn/SBPd >0.8 and ≤0.9; nondipper = SBPn/SBPd >0.9 and ≤1.0; reverse dipper = SBPn/SBPd ≥1.0. *P < 0.05, **P < 0.001, ***P < 0.0001 vs. other 3 groups; † P < 0.05, † † P < 0.001, † † † P < 0.0001 vs. dippers and extreme dippers; ‡ P < 0.05, ‡ ‡ P < 0.001 vs. dippers; # P < 0.05, ## P < 0.001, ### P < 0.0001 vs. extreme dippers; $ P < 0.05 vs. nondippers. Abbreviations: BP, blood pressure; DBP, diastolic BP; E/A, early-to-late transmitral velocity; E/e', early transmitral blood flow velocity/mean of lateral and septal wall myocardial tissue lengthening at the mitral annulus; HbA 1c , glycosylated hemoglobin; HR, heart rate; Log HOMA-IR, Logarithm of homeostasis model of insulin resistance; LV, left ventricle; LVEDD, left ventricular end diastolic diameter; RWT, relative wall thickness; SBP, systolic BP; SBPd, day SBP; SBPn, night SBP; TPR, total peripheral resistance. β, beta coefficient; BMI, body mass index; BP, blood pressure; CI, confidence interval; DBPd, day DBP; DBPn, night DBP; DBPn/DBPd ratio, ratio of night DBP to day DBP; E/A, left ventricular early-to-late transmitral flow velocity; E/e', early transmitral blood flow velocity/mean of lateral and septal wall myocardial tissue lengthening at the mitral annulus; EF, ejection fraction; endFS, endocardial fractional shortening; HbA 1c , glycosylated hemoglobin; LVMI, left ventricular mass indexed to height 1.7 ; RWT, relative wall thickness; SBPd, day SBP; SBPn, night SBP; SBPn/SBPd ratio, ratio of night SBP to day SBP; mFS, midwall fractional shortening. adjusted EF (69.5 ± 0.6% vs. 67.7 ± 0.5%, P = 0.04) and endFS (39.7 ± 0.5% vs. 38.3 ± 0.5%, P = 0.05) but not mFS (26.2 ± 0.5% vs. 25.4 ± 0.5%, P = 0.25) were decreased. When nondippers were compared to dippers defined according to diastolic BP, adjusted EF (69.1 ± 0.5% vs. 66.3 ± 1.0%, P = 0.01), endFS (39.4 ± 0.4% vs. 37.3 ± 0.8%, P = 0.02), and mFS (26.1 ± 0.4% vs. 24.3 ± 0.7%, P = 0.03) were decreased. Figure 2 shows the impact of further adjustments for TPR on the multivariate-adjusted mean values of indexes of cardiac systolic function in the 4 BP dipping patterns. After further adjustments for TPR, EF, endFS, and mFS remained increased in the extreme dippers compared to the other 3 groups, when dipping pattern was defined according to systolic BP (Figure 2, upper panels) . When dipping pattern was defined according to diastolic BP, further adjustments for TPR also had no impact on the decreased EF, endFS, and mFS in the reverse dippers compared to the other 3 groups (Figure 2 , lower panels).
Impact of TPR on relationships between BP dipping pattern and indexes of cardiac systolic function
DISCUSSION
The main findings of the present study are as follows: In participants from a community sample who were not receiving antihypertensive therapy, BP dipping and hence nocturnal but not day BP was associated with indexes of cardiac systolic function independent of confounders including 24 hour (or day) BP, LVMI, and RWT. Hence, it is possible that blunted nocturnal BP dipping contributes to a reduced cardiac systolic function prior to the development of HF with a reduced systolic function. The negative impact of BP dipping on cardiac systolic function was not explained by variations in PWV or HOMA-IR, but was in-part explained by variations in TPR.
To our knowledge, only 3 previous studies have assessed the impact of BP dipping on cardiac systolic function in untreated participants. [9] [10] [11] In a small study sample (n = 56) of untreated hypertensive participants, 9 EF was reduced in nondippers (defined as absence of nocturnal BP fall [day MAP minus night MAP/day MAP × 100%] ≥10%) compared to dippers. However, in comparing these 2 groups, no adjustments were made for potential confounding variables. Similarly, in a study including hypertensives with LV hypertrophy (n = 75), hypertensives without LV hypertrophy (n = 35), and normotensives (n = 23), none of whom were receiving antihypertensive therapy, decreases in EF and increases in BNP and ANP were reported in nondippers (defined as night/day MAP >0.9) compared to dippers, without adjustments for confounding variables. 10 In this regard, the nondippers were older than the dippers; but no data on BMI were given. In a large cohort (n = 1702), of never-treated essential hypertensives, those with depressed endFS or mFS in the absence of HF, had reduced day-night BP changes compared to patients with normal endFS or mFS. 11 Moreover, after adjustments for age and gender, the night-to-day systolic BP ratio was associated with both β, beta coefficient; BMI, body mass index; BP, blood pressure; CI, confidence interval; DBPd, day DBP; DBPn, night DBP; DBPn/DBPd ratio, ratio of night DBP to day DBP; EF, ejection fraction; endFS, endocardial fractional shortening; HbA 1c , glycosylated hemoglobin; Log HOMA-IR, logarithm homeostasis model of insulin resistance; LVMI, left ventricular mass indexed to height 1.7 ; mFS, midwall fractional shortening; PWV, pulse wave velocity RWT, relative wall thickness; SBPd, day SBP; SBPn, night SBP; SBPn/SBPd ratio, ratio of night SBP to day SBP; TPR, total peripheral resistance.
a Adjusted for age, sex, BMI (only body weight for LVMI), regular smoking, regular alcohol consumption, diabetes or HbA 1c > 6.1%, 24-hour pulse rate, 24-hour BP. Table 4 . Continued endocardial and midwall FS in these patients. 11 However, in that study 11 despite higher LVMI values and a more concentric geometry in patients with a depressed endFS and mFS, associations between night-to-day BP ratios and FS were only adjusted for age and gender. Hence, in that study, 11 LV concentric hypertrophy may have explained the relationship between night-to-day BP ratio and FS. Indeed, FS showed stronger relationships with LVM than with night-to-day BP ratio. 11 Our data strengthen these previous reports, [9] [10] [11] by indicating in a relatively large study sample of untreated participants that indexes of cardiac systolic function are associated with nocturnal BP dipping and nocturnal but not day BP independent of several possible confounding variables. Importantly, we report that these associations are independent of LVMI and RWT, which are associated with both BP dipping 21 and cardiac dysfunction. Although the multivariate-adjusted associations reported in the current study are fairly weak (correlation coefficients ranging from −0.10 to −0.15), they translated into differences of 6.6% in EF, 5.5% in endFS, and 4.3% in mFS between extreme dippers and reverse dippers. In addition, the associations reported in the current study are similar to the correlation coefficients of −0.07 between night-to-day SBP ratio and endFS, and −0.09 between night-to-day SBP ratio and mFS, previously reported. 11 In the current study, nondipping was due to a higher night but not day BP. Neurohormonal factors implicated in blunted nocturnal dipping include increased activation of the sympathetic nervous system 6 and the renin-angiotensinaldosterone system. 7 In addition, nondippers have increased plasma catecholamine concentrations 34 and a decrease in the activity of the parasympathetic nervous system 35 compared to dippers. With respect to the increased sympathetic nervous system activation, blunted nocturnal dipping is mediated by elevated nocturnal norepinephrine levels (reduced nocturnal fall in excretion of norepinephrine) which are not related to physical or mental activity. 6 In addition, increased alpha-1 adrenergic receptor responsiveness in the absence of changes in beta adrenergic receptor responsiveness occurs in nondippers compared to dippers. 6 The heightened sympathetic nervous system activity during sleep would translate into increases in nocturnal BP secondary to increases in TPR. Indeed, in the present study increases in TPR were noted in the reverse dippers compared to the other 3 groups. The increased TPR in the reverse dippers is likely to reflect an enhanced vasoconstriction mediated by augmented sympathetic nervous system activity in this group. Indeed, the reverse dippers had an increased night HR compared to the dippers which could be attributed to increased sympathetic nervous system activity and/or decreased parasympathetic nervous system activity at night.
Possible explanations for the association of BP dipping with cardiac systolic function warrant discussion. In this regard, although BP dipping has been associated with aging, 15, 16 male gender, 15, 16 obesity, 15, 16 and BP level, 16 only age is associated with BP dipping independent of daytime .1%, 24-hour heart rate, and 24 hour SBP or DBP. *P < 0.05, **P < 0.005, ***P < 0.0005 vs. extreme dippers; † P < 0.0005 vs. dippers; # P < 0.005 vs. nondippers. Abbreviations: BP, blood pressure; DBP, diastolic BP; EF, ejection fraction; endFS, endocardial fractional shortening; HbA 1c , glycosylated hemoglobin; mFS, midwall fractional shortening; SBP, systolic BP.
BP. 15 Other factors reported to be associated with BP dipping include insulin resistance 17 and PWV. 18, 19 In this regard, hypertensives who were reverse dippers are reported to have higher multivariate-adjusted PWV compared to dippers or nondippers. 18 Indeed, PWV is reported to be an independent predictor of diminished nocturnal BP dipping. 19 In addition, in patients with essential hypertension, increases in LVMI and RWT have been reported in nondippers compared to dippers. 21 Hence, in order to determine the independent effect of reduced BP dipping on cardiac systolic function, adjustments for these confounding factors are paramount, an approach not conducted in previous studies. [9] [10] [11] In the present study, the negative impact of blunted BP dipping on cardiac systolic function was independent of the potential confounding effects of age, gender, obesity, LVMI, RWT, and BP level. However, TPR which was increased in the reverse dippers compared to the other 3 groups in-part explained the inverse relationship between SBP dipping and mFS. Conversely, the negative relationship between dipping and systolic function may reflect reverse causality. Indeed, reductions in systolic function would reduce BP, hence resulting in compensatory vasoconstriction and an increase in TPR. Nevertheless, the lack of impact of adjustments for TPR on the relationship between nondipping and endFS in the present study may be a consequence of TPR being calculated during the day rather than at night. Hence, further studies are required to determine whether increases in nocturnal TPR account for the negative relationship between dipping and systolic function.
Although, the relationships between BP dipping and cardiac function in patients who are in HF are difficult to interpret, it is worth noting that previous studies have reported an association between nondipping and HF with reduced EF. 4, 36 In addition, in a longitudinal follow-up study (~9 years), night DBP and nondipping were predictors of the development of congestive HF independent of antihypertensive medication, myocardial infarction, diabetes, smoking, BMI, serum cholesterol, and 24-hour ambulatory BP. 36 In contrast, a high morning surge of BP (>23 mm Hg) in dippers was independently associated with risk of development of HF with reduced EF, whereas nondipping was independently associated with risk of development of HF with preserved EF over ~9 years in elderly hypertensive patients. 36 The present data are of clinical importance as they indicate that blunted nocturnal BP dipping is associated with reduced cardiac systolic function prior to the development of HF with a reduced EF. The implications are that the reversal of BP dipping could be beneficial in the prevention and/ or slowing of the progression from cardiac systolic dysfunction to HF with reduced EF. In this regard, a number of studies have reported the restoration of BP dipping after the administration of various antihypertensive agents. [12] [13] [14] However, longitudinal studies are required to determine whether changes in BP dipping translate into changes in cardiac systolic function.
The limitations of the present study are the cross-sectional, rather than prospective nature of the study design and the lack of outcomes data. Although cause and effect cannot Figure 2 . Impact of further adjustment for TPR on multivariate-adjusted mean values of indexes of cardiac systolic function in the 4 BP dipping patterns defined according to SBP dipping (upper panels) or DBP dipping (lower panels). Adjustments are for age, sex, body mass index, regular smoking, regular alcohol consumption, diabetes mellitus and/or HbA 1c > 6.1%, 24-hour heart rate, 24-hour SBP or DBP and TPR. *P < 0.05, **P < 0.005, ***P < 0.0005 vs. extreme dippers; † P < 0.005 vs. dippers; # P < 0.01 vs. nondippers. Abbreviations: BP, blood pressure; DBP, diastolic BP; EF, ejection fraction; endFS, endocardial fractional shortening; HbA 1c , glycosylated hemoglobin; mFS, midwall fractional shortening; SBP, systolic BP; TPR, total peripheral resistance.
be concluded from a cross-sectional study, it is important to note that in a small study (n = 42), the restoration of BP dipping, with calcium channel blocker therapy in 8 patients with hypertension and diabetes mellitus, was associated with increases in EF. 37 No changes in EF were noted in the patients in whom BP dipping patterns remained unaltered after calcium channel blocker therapy. 37 Secondly, as the data were collected in a population consisting predominantly of women, it is possible that the results of the present study pertain primarily to women. As the current data were collected in a cross-sectional population (27% hypertensive) of participants of Black African ancestry, and previous data were collected in hypertensive and normotensive Caucasian patients, 10, 11 or in hypertensive and normotensive patients from Japan, 9 it is unlikely that these data pertain only to hypertensives or to participants of Black African ancestry.
In conclusion, the results of the present study suggest that blunted nocturnal BP dipping is implicated in reductions in cardiac systolic function. Moreover, the data suggest that the relationships between BP dipping and indexes of cardiac systolic function are not explained by variations in insulin resistance, arterial stiffness, LVMI, or concentric LV remodeling but are associated with an increased nocturnal BP which may in-part be determined by variations in vascular resistance. Further longitudinal studies are, however, required to assess whether changes in BP dipping status translate into changes in cardiac systolic function in the absence of HF.
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